← Leaderboards
Wilson S Meng
University Of Pittsburgh At Pittsburgh
$1,564,323
Attributed
$1,882,040
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $357.1K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,882,040 · 6
By mechanism
R21$1,332,935 · 4
R15$549,105 · 2
Top collaborators
- Kerry Mcgarr Empey2 shared
- Yong Fan1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Alison Morris$31,399,077
- Cristian Apetrei$24,938,676
- Matthew S Freiberg$20,071,860
- Cameron S. Carter$36,474,007
- Fadi G. Lakkis$19,632,585
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoT Cell ResponseDoseInflammationAcuteAntigen-Presenting CellsCytokineAntibodiesInfectionGenerationsIn VitroInnovationDrug Delivery SystemsPeptidesHospitalizationResponseDesignCellsFormulationAllograftingAllogenicMolecularSiteT-Lymphocyte
Grant awards (10)
Injectable 3D-Clustered Human Fibroblastic Reticular Cells for Expanding Regulatory T Cells$231,131
R21 · FY2025 · AI · contact PI
Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein$177,591
R21 · FY2024 · AI
Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein$226,713
R21 · FY2023 · AI
Development of a Regulatory T Cell Mimetic for Tolerance Induction in Skin Transplantation$142,957
R21 · FY2020 · AI · contact PI
DEVELOPMENT OF A REGULATORY T CELL MIMETIC FOR TOLERANCE INDUCTION IN SKIN TRANSPLANTATION$47,784
R21 · FY2020 · AI · contact PI
Development of a Regulatory T Cell Mimetic for Tolerance Induction in Skin Transplantation$186,863
R21 · FY2019 · AI · contact PI
A Biomaterial Approach to Attenuate Rejection of Skin Allografts$139,464
R21 · FY2015 · AI · contact PI
A Biomaterial Approach to Attenuate Rejection of Skin Allografts$180,432
R21 · FY2014 · AI · contact PI
Non-viral Genetic Modification of Antigen-presenting Cells in Allografts$357,100
R15 · FY2011 · AI · contact PI
Rational Design of Peptide-Based Tumor Vaccine$192,005
R15 · FY2004 · CA